Vanadium (V) at naturally occurring concentrations has been shown to be a significant inhibitor of (Na+, K+) ATPase, the enzyme responsible for the sodium pump reaction. Although there are conflicting data, it has been suggested that high vanadium levels may shut down the enzyme and lead to hypertension. Vanadium appears to cycle between the (IV) (inactive) and (V)(active) oxidation states. Glutathione is thought to be the reducing agent for the (V) to (IV) step, but little is known about the complexes that exist in the two oxidation states or how vanadium (IV) is oxidized. One study shows that glutathione also forms a complex with vanadium (IV). Due to the lack of knowledge of redox chemistry of vanadium in this system, this proposal is for fundamental studies of model complexes. Model complexes with glutathione, cysteine and penicillamine will be synthesized and characterized by electrochemical and spectroscopic techniques. The immediate goal is to elucidate the fundamental chemistry of such model systems. The ultimate goal is to mimic the effect of vanadium in vivo.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15HL037252-01
Application #
3439984
Study Section
Metallobiochemistry Study Section (BMT)
Project Start
1986-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1988-09-29
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Miami University Oxford
Department
Type
Schools of Arts and Sciences
DUNS #
041065129
City
Oxford
State
OH
Country
United States
Zip Code
45056